HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nicolai Härtel Selected Research
Nicolai Härtel Research Topics
Disease
6
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2016
6
Neoplasms (Cancer)
01/2022 - 11/2006
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2012 - 11/2006
2
Leukemia
05/2008 - 11/2006
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1
Carcinoma (Carcinomatosis)
06/2020
1
Adenocarcinoma
12/2019
1
Disease Progression
01/2019
1
Adenoma (Adenomas)
10/2017
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2008
Drug/Important Bio-Agent (IBA)
3
Pharmaceutical Preparations
IBA
01/2022 - 11/2006
3
Imatinib Mesylate (Gleevec)
FDA Link
02/2012 - 11/2006
2
Biomarkers (Surrogate Marker)
IBA
07/2019 - 05/2008
2
Bevacizumab (Avastin)
FDA Link
07/2019 - 01/2016
2
nilotinib
FDA Link
02/2012 - 05/2008
1
Biological Products
IBA
01/2022
1
Trastuzumab (Herceptin)
FDA Link
12/2019
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2019
1
Aryl Hydrocarbon Receptor Nuclear Translocator
IBA
07/2019
1
Immune Checkpoint Inhibitors
IBA
01/2019
1
Cell-Free Nucleic Acids
IBA
01/2019
1
Calcibiotic Root Canal Sealer
IBA
10/2017
1
Messenger RNA (mRNA)
IBA
10/2017
1
Dasatinib (BMS 354825)
FDA Link
02/2012
1
Tyrosine Kinase Inhibitors
IBA
02/2012
1
Phosphotransferases (Kinase)
IBA
05/2008
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2006
1
2-acylglycerophosphate acyltransferase
IBA
11/2006
Therapy/Procedure
5
Therapeutics
06/2020 - 01/2016
2
Drug Therapy (Chemotherapy)
01/2022 - 01/2022
1
Aftercare (After-Treatment)
01/2022
1
Polypharmacy
06/2020
1
Operative Surgical Procedures
06/2020
1
Immunotherapy
01/2019
1
Combination Drug Therapy (Combination Chemotherapy)
01/2016